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Objectives: The innate immune response contributes
to the skeletal muscle damage in patients with critical
limb ischaemia (CLI); however, the detailed signalling
mechanisms are not fully understood. We hypothesised
that simulated ischaemia induces inﬂammatory cytokine
release from skeletal myotubes, via a mechanism that
involves heat shock protein (HSP) 60&70, known
endogenous ligands of Toll-like receptor 4 (TLR4), in
vitro.
Methods: Human gastrocnemius muscle biopsies
were taken from patients with CLI undergoing major
lower limb amputation and from patients with no periph-
eral arterial disease (PAD). Human myoblasts were iso-
lated, cultured to myotubes and then pretreated with
TLR4 neutralizing antibody prior to exposure to simulated
ischaemia. Fluorescent immunostaining was carried out to
conﬁrm cell differentiation; ELISA analysis were carried
out to quantify IL6 and TNF-a release; and Western blot
was used to assess expression of HSP60&70, TLR4 and
cleaved caspase-3 as a marker of apoptosis.
Results: Myotubes from patients with CLI expressed
greater levels of cleaved caspase-3 and TLR4 as compared
to those from patients with no PAD. When exposed to
ischaemic conditions, increased IL6 and TNF-a release
and upregulation of HSP60&70, cleaved caspase-3 and
TLR4 were observed in myotubes from both groups of
patients compared to culturing in normoxic conditions
(P < .05). Pretreatment of myotubes from patients withCLI with TLR4 neutralizing antibody prior to simulated
ischaemia was associated with reduced expression of
HSP60&70, IL6, TNF-a and cleaved caspase-3 (P < .05).
Conclusions: Increased cytokine release, apoptosis
and expression of HSP60&70 and TLR4 occur in ischae-
mic skeletal muscle in vitro. TLR4 antagonism was associ-
ated with reduced apoptosis and inﬂammatory cytokine
release and down-regulation of HSP60&70 expression.
Here we report an intimate link between HSP60&70-
induced inﬂammatory cytokine production and TLR4 inhi-
bition in ischaemic human myotubes.
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Objectives: Transplant arteriosclerosis (TA) is an
accelerated form of atherosclerosis largely driven by the
immune response to the allograft. As for all atherosclerotic
disease, inﬂammation is central to vascular remodeling
associated with TA. We have shown that the potent NF-
kB inhibitory protein A20 exerts atheroprotective effects,
in part through its anti-inﬂammatory and antiapoptotic
functions in endothelial cells (EC), its anti-inﬂammatory,
and anti-proliferative functions in smooth muscles cells
(SMC), and its speciﬁc pro-apoptotic function in neointi-
mal SMC. In this work, we wanted to check the physio-
logic role that A20 plays in the vascular remodeling
associated with transplant arteriosclerosis by performing
loss of function experiments in a mouse model of TA.
Methods: We used a murine vascular transplant
model, implanting aortae of 8-12 week old C57bL/6
mice into the carotid arteries of fully HLA mismatched
Balb/c mice. For our donors, we used aortic grafts from
C57bL/6 A20 heterozygote mice (HET) or from their
wild-type littermates (WT). Aortic allografts were har-
vested after 10 days and 4 weeks.
Results: Partial loss of A20 in aortic allografts caused
signiﬁcantly greater TA lesions, measured by intima over
media ratios in wild type allografts. This was associated
with higher inﬂammation as evaluated by VCAM-1 immu-
nostaining and granulocyte inﬁltration, lower expression of
the anti-inﬂammatory and tolerogenic cytokine IL-10, and
greater incidence of thrombosis in HET allografts.
Conclusions: We conclude that A20 plays an impor-
tant physiologic role in vascular remodeling, and propose
that tailored A20-based vascular therapies could decrease
incidence and severity of TA, and synergize with or mini-
mize use of immunosuppression in solid organ transplanta-
tion. These results are particularly relevant to newly
discovered A20 single nucleotide polymorphisms that are
less effective in inhibiting inﬂammation, and have been
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Objectives: Erythropoietin (Epo) has tissue-protective
effects in response to injury, acting through the EpoR-bcR
heteroreceptor. We have previously demonstrated the pres-
ence and interaction of the EpoR and bcR in human skel-
etal muscle. Here we aim to investigate the potential
cytoprotective effects of Epo and an Epo-derivative
(ARA-290) in a human in vitro model of skeletal muscle
and establish a potential downstream signalling pathway
utilized in protecting cells from apoptosis (including
Jak-2, PI3k/Akt, NFkB).
Methods: Gastrocnemius muscle biopsies were ob-
tained from patients with critical limb ischemia and control
samples were obtained from non-ischemic patients.
Human myoblasts were isolated from muscle biopsies,
cultured, and allowed to differentiate into myotubes in
order to investigate the cytoprotective effects of Epo and
ARA-290 on myotubes subjected to simulated ischemia.
The PI3k inhibitors, LY294002 and wortmannin, were
then used to determine the role of PI3k/Akt pathway in
mediating cytoprotection. Following this, inhibitors against
the upstream (Jak-2) and downstream (NFkB) moleculesFig. Plots showing the relationships between aneurysm exp
uniform wall thickness models, and peak wall stress from varwere also investigated. Western blot analysis, using the
pro-apoptotic marker cleaved caspase-3 was performed
and compared with levels of Akt and phosphorylated-Akt,
using western blot analysis.
Results: Exogenous administration of Epo and ARA-
290 were able to ameliorate the ischemia-induced
apoptosis on isolated human myotubes as shown by a signif-
icant reduction in cleaved caspase-3 expression. Addition of
all inhibitors, to ARA-290 or Epo pretreated cells, abol-
ished the reduction in apoptosis.
Conclusions: The ability of ARA-290 to attenuate
apoptosis in human myotubes undergoing ischemic insult
suggests a potential role in tissue protection in skeletal
muscle injury. We propose that the PI3k/Akt signalling
pathway is involved in mediating this cytoprotection.
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Objectives: Growing evidence suggests that peak wall
stress (PWS) derived from ﬁnite element analysis (FEA) of
abdominal aortic aneurysms (AAAs) predicts clinical
outcomes better than diameter alone. Prior models assume
uniform wall thickness (UWT). We hypothesize that the
inclusion of locally variable wall thickness (VWT) into FEA
of AAAs will improve its ability to predict clinical outcomes.
Methods: Patients with AAAs (n ¼ 26) undergoing
radiologic surveillance were identiﬁed. Custom MATLAB
algorithms generated UWT and VWT aortic geometries
from CTA images, which were subsequently loaded with
systolic blood pressure using FEA. PWS and aneurysmansion and initial aortic diameter, peak wall stress from
iable wall thickness models.
